Biotech | December 24, 2021
Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis
Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000
